Global & Regional Health Technology Assessment

Scope & Guideline

Advancing insights in health technology assessment.

Introduction

Welcome to the Global & Regional Health Technology Assessment information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Global & Regional Health Technology Assessment, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN2284-2403
PublisherABOUTSCIENCE SRL
Support Open AccessYes
Country-
TypeJournal
Convergefrom 2014 to 2016, from 2019 to 2024
AbbreviationGLOB REG HEALTH TECH / Glob. Reg. Health Technol. Assess.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPIAZZA DUCA D AOSTA, 12, MILAN, MI 20124, ITALY

Aims and Scopes

The journal 'Global & Regional Health Technology Assessment' focuses on the evaluation of health technologies and their impact on health systems, particularly in the context of global and regional healthcare settings. It emphasizes the economic, clinical, and social aspects of health technology assessment (HTA) to inform policy and practice.
  1. Health Technology Evaluation:
    The journal aims to provide comprehensive evaluations of various health technologies, including pharmaceuticals, medical devices, and diagnostic tools, focusing on their clinical efficacy, safety, and cost-effectiveness.
  2. Economic Impact Analysis:
    It emphasizes the importance of economic evaluations, including cost-effectiveness and budget impact analyses, to assess the financial implications of health interventions on healthcare systems.
  3. Real-World Evidence:
    The journal prioritizes studies that utilize real-world data to evaluate health technologies, thereby informing clinical practice and healthcare decision-making with practical insights.
  4. Policy Recommendations:
    It aims to influence health policy by providing evidence-based recommendations for the pricing, reimbursement, and regulation of health technologies.
  5. Patient-Centered Outcomes:
    The journal also focuses on the assessment of patient-reported outcomes and their significance in evaluating the impact of health technologies on patient quality of life.
Recent trends in the journal's publications show a clear movement towards specific themes that are gaining traction. This section outlines the emerging topics that reflect the evolving landscape of health technology assessment.
  1. Patient-Centered Approaches:
    There is an increasing emphasis on incorporating patient-reported outcomes and experiences into health technology assessments, reflecting a broader trend towards patient-centered care.
  2. Real-World Data Utilization:
    The use of real-world data for evaluating the effectiveness and economic impact of health technologies is becoming more prevalent, indicating a shift towards evidence that reflects actual clinical practice.
  3. Innovative Pricing and Reimbursement Models:
    Emerging discussions around innovative pricing strategies and reimbursement models for new therapies highlight the need for adaptive approaches in light of evolving healthcare landscapes.
  4. Impact of COVID-19 on HTA:
    The journal is increasingly addressing the implications of the COVID-19 pandemic on health technology assessments, including changes in regulatory processes and the prioritization of certain health technologies.
  5. Multicriteria Decision Analysis (MCDA):
    The application of multicriteria decision analysis in health technology assessment is gaining attention, providing a structured approach to evaluate complex decisions involving multiple stakeholders.

Declining or Waning

While the journal has a broad and dynamic scope, certain themes have seen a decline in prominence over the recent years. This section highlights those areas that appear to be less frequently addressed in recent publications.
  1. Traditional Clinical Trials:
    There is a noticeable decline in the focus on traditional randomized controlled trials as the primary method for evaluating health technologies, with a growing preference for real-world evidence.
  2. General Health Economics:
    The broader field of health economics, while still relevant, seems to be overshadowed by more focused analyses such as cost-effectiveness and budget impact specific to particular diseases or therapies.
  3. Regulatory Frameworks:
    Discussions centered around the regulatory frameworks for HTA processes have decreased, indicating a potential shift towards more practical applications and outcomes of HTA rather than the processes themselves.

Similar Journals

JAMA Internal Medicine

Pioneering Research that Transforms Clinical Practices
Publisher: AMER MEDICAL ASSOCISSN: 2168-6106Frequency: 12 issues/year

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

Value in Health Regional Issues

Fostering Multidisciplinary Collaboration in Health Economics.
Publisher: ELSEVIERISSN: 2212-1099Frequency: 3 issues/year

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

Health Policy and Technology

Elevating healthcare discourse through rigorous research.
Publisher: ELSEVIER SCI LTDISSN: 2211-8837Frequency: 4 issues/year

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

MDM Policy & Practice

Transforming Public Health with Innovative Research
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

Health Economics Review

Shaping a healthier future with cutting-edge analysis.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

ClinicoEconomics and Outcomes Research

Innovating Healthcare Decisions with Economic Insights
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6981Frequency: 1 issue/year

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

ADVANCES IN THERAPY

Advancing therapeutic knowledge for a healthier tomorrow.
Publisher: SPRINGERISSN: 0741-238XFrequency: 12 issues/year

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

PHARMACOECONOMICS

Shaping policy through innovative pharmacoeconomic research.
Publisher: ADIS INT LTDISSN: 1170-7690Frequency: 12 issues/year

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

Risk Management and Healthcare Policy

Navigating the complexities of healthcare risk with expert analysis.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Risk Management and Healthcare Policy is an esteemed Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of health policy and public health. Established in 2008, the journal fosters a rich dialogue among researchers, professionals, and students, focusing on innovative strategies for managing risks within healthcare systems. With a current impact factor reflected in its robust Scopus rankings—placing it in the top quartile (Q2) in both Health Policy and Public Health, Environmental and Occupational Health—the journal is a pivotal resource that shares critical insights and evidence-based practices. The journal not only covers empirical studies and analytical research but also promotes discussions on emerging challenges and opportunities within the healthcare sector. As a result, Risk Management and Healthcare Policy serves as a vital platform for disseminating high-quality research, fostering collaboration, and informing policy decisions aimed at enhancing health outcomes globally.

Journal of Health Economics and Outcomes Research

Advancing health policy through innovative research.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.